Cargando…
The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing
Autores principales: | Davies, Emma, Whitfield, Tom, Machin, Nicholas, Ahmad, Shazaad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239002/ https://www.ncbi.nlm.nih.gov/pubmed/32504943 http://dx.doi.org/10.1016/j.jcv.2020.104449 |
Ejemplares similares
-
Real-world SARS CoV-2 testing in Northern England during the first wave of the COVID-19 pandemic
por: Farooq, Hamzah Z., et al.
Publicado: (2021) -
Middle East respiratory syndrome coronavirus (MERS-CoV) — Surveillance and testing in North England from 2012 to 2019
por: Farooq, Hamzah Z., et al.
Publicado: (2020) -
The Relationship between Helicobacter pylori and Beta-2 Microglobulin in Humans
por: Yeniova, Abdullah Özgür, et al.
Publicado: (2014) -
Increased urinary beta 2-microglobulin in cadmium exposure: dose-effect relationship and biological significance of beta 2-microglobulin.
por: Tsuchiya, K, et al.
Publicado: (1979) -
Expression of beta-2-microglobulin by nasopharyngeal carcinoma.
por: Shiu, W., et al.
Publicado: (1992)